Eli Lilly is a medicine company turning science into healing to make life better for people around the world.
Harnessing the power of biotechnology, chemistry and genetic medicine, Lilly scientists are urgently advancing science to solve some of the world's most significant health challenges. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better."
But Lilly not only dedicated to making medicines. Company goes beyond medicine to deliver
innovative clinical trials the diversity of our world and work to ensure our medicines are
accessible and affordable.
Company’s total workforce is 46 913 employees. In relentless pursuit to help the most people around the world, Lilly’s pipeline is focused on the following key areas: Alzheimer’s, Obesity, Immunology, Pain, Cancer and Diabetes.
Key facts related to Research and Development:
2024 expenditures
- $10,990.6 million
- Research and Development as a percentage of sales: 24.4%
- Employees engaged in Research and Development activities: 11,169
- Percentage of total workforce: 23.7%
- Clinical research conducted in more than 55 countries
- Research and Development facilities located in 8 countries